AUSTIN, TX—Duloxetine, pregabalin, and duloxetine + gabapentin were found to be safe and tolerable for the treatment of diabetic peripheral neuropathic pain, according to results presented today at ...

A painkiller meant for relief now faces tighter scrutiny as abuse concerns spill into policy.

The efficacy of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy has been established in several controlled clinical trials. [17,18,19] These trials ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rsgskj/lyrica) has announced the addition of the "Lyrica (Neuropathic Pain ...

The American Diabetes Assocation emphasizes stabilization of glycemic control and the use of tricyclic antidepressants (TCAs) followed by anticonvulsants and opioids. [23] Guidelines from the British ...

Non-Habit Forming: Unlike Pregabalin, Ketamir-2 carries no known risk of dependence, making it safer for long-term use. Fewer Cognitive Side Effects: With the potential to avoid sedation and cognitive ...